A novel irreversible inhibitor of acetylcholinesterase specifically directed at the anionic binding site: structure-activity relationships.
D000110:Acetylcholinesterase / Q000096:biosynthesis*; D000818:Animals; D001389:Azirines / Q000494:pharmacology; D002417:Cattle; D004798:Enzymes / Q000494:pharmacology*; D004912:Erythrocytes / Q000378:metabolism; D011220:Pralidoxime Compounds / Q000494:pharmacology
D001389:Azirines; D004798:Enzymes; D011220:Pralidoxime Compounds; D000110:Acetylcholinesterase